Business Context and Reporting Period
Creative Medical Technology Holdings, Inc., a Nevada corporation, filed this Form 8-K on November 2, 2021. The report details corporate governance actions approved by the Board of Directors and filed with the Secretary of State of Nevada on the same date.
Key Financial Metrics
This filing is a current report regarding corporate structure and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Preferred Stock Withdrawal: The Company filed Certificates of Withdrawal for its Series B and Series C Convertible Preferred Stock. The filing confirms that no shares of these series were outstanding at the time, as they had previously been exchanged for Bridge Notes issued in August 2021.
- Authorized Share Increase: The Company amended its Articles of Incorporation to increase the number of authorized common shares from 6,000,000,000 to 25,000,000,000. This amendment became effective upon filing on November 2, 2021.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, or an outlook for future performance. No specific risks or contingencies are discussed beyond the structural changes to the capitalization table.
Investor Verification Checklist
- Verify the effective date of the authorized common share increase (November 2, 2021) and the new total of 25 billion shares.
- Confirm the status of the Series B and Series C Convertible Preferred Stock to ensure no outstanding shares remain following the withdrawal.
- Review the August 2021 Bridge Notes issuance to understand the conversion mechanics that eliminated the preferred stock.
- Check subsequent filings for any issuances of common stock against the newly authorized 25 billion share limit.